Market Tracker

12/18 6:05pm ET

Repligen Corp (NASDAQ:RGEN)

During the Trading Day
21.55 +0.63 / +3.01%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
21.55 +0.0026 / +0.01%
 
Volume: 2.8K
No recent news for Repligen Corp.

Today’s Trading

Previous close20.92
Today’s open21.02
Day’s range20.89 - 21.74
Volume360,911
Average volume (3 months)370,027
Market cap$684.5M
Dividend yield--
Data as of 4:00pm ET, 12/18/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-47.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.48%
P/E ratio59.9
Price/Sales6.34
Price/Book6.43

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+1.68+11.69%
TGTXTG Therapeutics Inc-0.72-4.38%
FLMLFlamel Technologies ...-0.17-1.02%
OMEROmeros Corp+0.77+3.58%
Data as of 4:00pm ET, 12/18/2014

Financials

Next reporting dateMarch 5, 2015
EPS forecast (this quarter)$0.03
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts